BEVACIZUMAB-ADCD

203 reported adverse events

Drug classes: Vascular Endothelial Growth Factor Inhibitor [EPC]

These side effects are most commonly reported by patients taking BEVACIZUMAB-ADCD:

# Side effect Count
0 INTENTIONAL PRODUCT USE ISSUE 28
1 NEUTROPENIA 27
2 DIARRHOEA 18
3 NEUROPATHY PERIPHERAL 16
4 PYREXIA 13
5 ASTHENIA 12
6 THROMBOCYTOPENIA 12
7 NAUSEA 11
8 DRUG INEFFECTIVE 9
9 VOMITING 9
See all common reactions for BEVACIZUMAB-ADCD

BEVACIZUMAB-ADCD is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HYPOHAEMOGLOBINAEMIA 2 0.1176
1 CHRONIC DISEASE DECOMPENSATION 2 0.0714
2 MONOCYTOPENIA 2 0.0192
3 COLOSTOMY INFECTION 1 0.0167
4 TRACTIONAL RETINAL DETACHMENT 1 0.0090
5 STOMA PROLAPSE 1 0.0070
6 PERINEPHRIC ABSCESS 1 0.0066
7 RETINAL CYST 1 0.0060
8 COR PULMONALE CHRONIC 1 0.0053
9 MYXOEDEMA 1 0.0045
See all enriched reactions for BEVACIZUMAB-ADCD